Aug. 16 at 4:12 PM
$MTEK
So, in order of potential impact:
1.
$5M–
$10M+ serial-production award
2. Named major defense prime/platform
3. U.S. Army or NATO production program
4. AS9100D leading directly to qualified-supplier status
5. Backlog jumping materially
6. Revenue returning toward/above the 2024
$6M level
7. Cash-flow breakeven or profitability
8. A strategic investment/acquisition by a larger defense company
The combination that could really re-rate MTEK would be something similar too
AS9100D → named prime qualification →
$5M+ production order → backlog expansion → recurring follow-on orders.
At MTEK’s size, they do not need a billion-dollar program. A handful of legitimate multi-million-dollar production contracts could change the entire financial profile. The risk is that the company still has limited cash and has already needed financing, so the contracts need to arrive before dilution becomes the dominant story.
